ClinicalTrials.Veeva

Menu

Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Daily Facial Cleanser

Galderma logo

Galderma

Status

Completed

Conditions

Skin Irritation

Treatments

Other: Cetaphil Daily Facial Cleanser

Study type

Interventional

Funder types

Industry

Identifiers

NCT01888887
GLI.04.SRE.US10236

Details and patient eligibility

About

Determine if Cetaphil Daily Facial Cleanser is a contact sensitizer or irritant to the skin

Enrollment

200 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Not currently under a doctor's care
  • Free of dermatological or systemic disorder which would interfere with the results
  • Free of any acute or chronic disease
  • Will complete a preliminary medical history form and are in general good health
  • Can read, understand, and sign informed consent

Exclusion criteria

  • Under 18 years old
  • Currently under doctor's care
  • Currently taking any medication
  • History of acute or chronic disease
  • Diagnosed with chronic skin allergies
  • Pregnant or lactating

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

200 participants in 1 patient group

Cetaphil Daily Facial Cleanser
Experimental group
Description:
All subjects receive Cetaphil Daily Facial Cleanser
Treatment:
Other: Cetaphil Daily Facial Cleanser

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems